Search Results - "Gobel, H."

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache by Silberstein, S D, Olesen, J, Bousser, M-G, Diener, H-C, Dodick, D, First, M, Goadsby, P J, Göbel, H, Lainez, M J A, Lance, J W, Lipton, R B, Nappi, G, Sakai, F, Schoenen, J, Steiner, T J

Get more information

Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan by Goadsby, P J, Zanchin, G, Geraud, G, de Klippel, N, Diaz-Insa, S, Gobel, H, Cunha, L, Ivanoff, N, Falques, M, Fortea, J

“…The study was designed to compare the response to almotriptan in migraine patients who take medication early in the course of the attack with that when…”
Get more information

Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine by Silberstein, S D, Schoenen, J, Göbel, H, Diener, H C, Elkind, A H, Klapper, J A, Howard, R A

“…Tonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine attacks. The ability of…”
Get more information

The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study by Göbel, H, Heinze, A

“…The 'Migraine Intervention Score' (MIS) is a new self-administered scale that can be used to quantify the severity of specific migraine symptoms. The objective…”
Get more information

Epidemiology and costs of chronic pain syndromes exemplified by specific and unspecific low back pain by Göbel, H

“…Low back pain is one of the most common factors leading to longtime disability. Unspecific low back pain is predominant, i. e. low back pain without an…”
Get full text

New appendix criteria open for a broader concept of chronic migraine by Olesen, J, Bousser, M-G, Diener, H-C, Dodick, D, First, M, Goadsby, P J, Göbel, H, Lainez, M J A, Lance, J W, Lipton, R B, Nappi, G, Sakai, F, Schoenen, J, Silberstein, S D, Steiner, T J

“…After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders,…”
Get more information

Classification of headaches by Göbel, H

“…It was not until 1962 that the Ad-Hoc Committee of the National Institute of Health first published a classification of headache syndromes by brief glossary…”
Get more information

A Physical-Based PSPICE Compact Model for Poly(3-hexylthiophene) Organic Field-Effect Transistors by Meixner, R.M., Gobel, H.H., Haidi Qiu, Ucurum, C., Klix, W., Stenzel, R., Yildirim, F.A., Bauhofer, W., Krautschneider, W.H.

“…A PSPICE model for organic thin-film transistors (OFETs) employing poly(3-hexylthiophene-2,5-diyl) (P3HT) is derived. This model is based on the standard…”
Get full text

Non pharmaceutical treatments for migraine by Göbel, H.

“…The target of non-drug treatment of migraine is to reduce attack frequency and intensity. To reach this goal, the general relationship between the patient and…”
Get full text

Petasites hybridus root (butterbur) is an effective preventive treatment for migraine by LIPTON, R. B, GOBEL, H, EINHÄUPL, K. M, WILKS, K, MAUSKOP, A

“…To evaluate the clinical efficacy of a standardized special root extract from the plant Petasites hybridus as a preventive therapy for migraine. This is a…”
Get full text

Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review by Mitsikostas, Dimos‐Dimtirios D., Caronna, Edoardo, De Tommaso, Marina, Deligianni, Christina I., Ekizoglu, Esme, Bolay, Hayrunnisa, Göbel, Carl H., Kristoffersen, Espen Saxhaug, Lampl, Christian, Moro, Elena, Pozo‐Rosich, Patricia, Sellner, Johann, Terwindt, Gisela, Irimia‐Sieira, Pablo

“…Background and purpose The aim was to provide insights to the characteristics of headache in the context of COVID‐19 on behalf of the Headache Scientific Panel…”
Get full text

Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks by Göbel, Carl H., Heinze, Axel, Cirkel, Anna, Göbel, Hartmut

“…Around 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or medical consultation. This therapeutic…”
Get full text

Efficacy of phenazone in the treatment of acute migraine attacks: a double-blind, placebo-controlled, randomized study by Göbel, H, Heinze, A, Niederberger, U, Witt, T, Zumbroich, V

“…In this study we compared the efficacy of 1000 mg phenazone with that of placebo in the treatment of acute migraine attacks in a randomized double-blind,…”
Get more information

Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study by Silberstein, S D, Göbel, H, Jensen, R, Elkind, A H, Degryse, R, Walcott, J M C M, Turkel, C

“…We studied the safety and efficacy of 0 U, 50 U, 100 U, 150 U (five sites), 86 Usub and 100 Usub (three sites) botulinum toxin type A (BoNTA; BOTOX); Allergan,…”
Get more information

Specialised pain therapy: does it pay for patients and health authorities? by Göbel, H

“…Specialized pain management centres have been shown to achieve significant clinical efficacy and a relevant reduction of direct and indirect costs…”
Get full text

ICHD-3 is significantly more specific than ICHD-3 beta for diagnosis of migraine with aura and with typical aura by Göbel, Carl H., Karstedt, Sarah C., Münte, Thomas F., Göbel, Hartmut, Wolfrum, Sebastian, Lebedeva, Elena R., Olesen, Jes, Royl, Georg

“…Background In the emergency room, distinguishing between a migraine with aura and a transient ischemic attack (TIA) is often not straightforward and mistakes…”
Get full text

Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence by Steiner, T. J., Göbel, H., Jensen, R., Lampl, C., Paemeleire, K., Linde, M., Braschinsky, M., Mitsikostas, D., Gil-Gouveia, R., Katsarava, Z.

“…In joint initiatives, the European Headache Federation and Lifting The Burden have described a model of structured headache services (with their basis in…”
Get full text

Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants by JURKAT-ROTT, K, FREILINGER, T, DREIER, J. P, HERZOG, J, GÖBEL, H, PETZOLD, G. C, MONTAGNA, P, GASSER, T, LEHMANN-HORN, F, DICHGANS, M

“…A1A2 Na+/K+-ATPase mutations cause familial hemiplegic migraine type 2 (FHM2). The authors identified three putative A1A2 mutations (D718N, R763H, P979L) and…”
Get full text

Prophylactic drug management of migraine by Göbel, H, Heinze, A

“…Migraine prophylaxis with drugs is still an essential part of migraine therapy. This is especially true for those patients with frequent migraines who are in…”
Get full text

Easy therapeutical management of sumatriptan-induced daily headache by GÖBEL, H, STOLZE, H, HEINZE, A, DWORSCHAK, M

Get full text